Cross-Cultural Adaptation of the Breast Cancer and Lymphedema Symptom Experience Index in Bengali
Bibliographic Data
Introduction: Breast cancer–related lymphedema is associated with a myriad of distressing symptoms and significantly impacts survivors’ quality of life. The Breast Cancer–related Lymphedema Symptom Experience Index (BCLE-SEI) is a validated patient-reported outcome measure (PROM), but is unavailable in Indian languages. This study aimed to cross-culturally adapt the BCLE-SEI into the Bengali language. Method: Following established guidelines, the BCLE-SEI was translated, back-translated, and validated in 168 Bengali-speaking women with or at risk of lymphedema. Results: Content validity was confirmed by ≥98% of participants. Exploratory factor analysis identified two factors in symptom occurrence and distress subscales, explaining 43.9% and 51% of the variance, respectively. Internal consistency (α) was >0.85, and construct validity was supported with over 50% of predefined hypotheses met. Test–retest reliability (intraclass correlation coefficient [ICC 2,1 ]) was .46 (95% confidence interval [CI] = [–0.2, 0.8], p = .076). Discussion: The BCLE-SEI-Bengali is a reliable and valid PROM for assessing lymphedema-related symptoms for Bengali-speaking women
Bengali · Breast cancer · Cancer · Confidence interval · Distress · Gynecology · Intraclass correlation · Lymphedema · Obstetrics · Physical therapy · Prom · Psychometrics · Quality of life (healthcare · Clinical Psychology · Lymphatic System and Diseases · Medicine · Nursing · Internal Medicine
Global cancer statistics 2022
Factor
Dimensionality assessment of ordered polytomous items with parallel analysis.
The European Organization for Research and Treatment of Cancer QLQ-C30
Sample size used to validate a scale
Assessing health-related quality of life in patients with breast cancer
Cosmin guideline for systematic reviews of patient-reported outcome measures
Exploratory Factor Analysis
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 1 |